Eli Lilly hits record high as healthcare stocks rally 

By Reuters News

** Shares of the world's largest drugmaker Eli Lilly LLY.N jump 5.45% to an all-time high of $1,307.91

** Stock's previous 52-week high was $1,292.65

** Wall Street coverage on the trillion-dollar stock tilts bullish with 29 analysts rating it "buy" or "strong buy", 3 rating "hold" and 1 "sell" with a median PT of $1,380.50, per LSEG data

** LLY has broadened its drug pipeline through a series of acquisitions and licensing deals, using the strong cash flow from its diabetes and weight-loss medicines to fuel a wider dealmaking push

** Other large-cap drugmakers including Amgen AMGN.O, Pfizer PFE.N, Johnson & Johnson JNJ.N and AbbVie ABBV.N were also up in morning trade, the broader S&P 500 Healthcare Index .SPXHC touched a record high

** Including session's move, LLY stock was up ~21% YTD

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk